✦ LIBER ✦

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

✍ Scribed by , Prof. Gavin R. Graff Professor and Chief Pediatric Pulmonology, John McNamara, James Royall, Steven Caras, Kristin Forssmann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S2059 Efficacy and Safety of Pancrelipas

✍ Trapnell, Bruce; Maguiness, Karen M.; Graff, Gavin R.; Boyd, David; Caras, Steve 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A 6-month, open-label clinical trial of

✍ N. Gubergrits; E. Malecka-Panas; G. A. Lehman; G. Vasileva; Y. Shen; S. Sander-S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

Efficacy and tolerability of a new formu

✍ Gavin R. Graff; Karen Maguiness; John McNamara; Ronald Morton; David Boyd; Katri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Efficacy and safety of a new formulation

✍ B.C. Trapnell; K. Maguiness; G.R. Graff; D. Boyd; S.D. Caras; K. Beckmann; D. Be 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 57 KB